Correlation between Systemic Arterial Hypertension and Bone Morphogenetic Protein-2 in Central Obese Non-Diabetic Men with Evidence of Coronary Artery Calcification

Antonia Anna Lukito, Allen Widyasanto, Trilis Yulianti, Rusli Muljadi, Andi Wijaya, Peter Kabo, Syakib Bakri

Abstract


BACKGROUND: Previous studies have confirmed separately the relationship between obesity, insulin-resistance, hypertension and bone morphogenetic protein-2 (BMP-2) with coronary artery calcification, a parameter of subclinical atherosclerosis. It was also reported that BMPs may function as proinflammatory, prohypertensive and proatherogenic mediators. The study aimed to assess the correlation between systemic hypertension and BMP-2 plasma concentration in central-obese non-diabetic men with evidence of coronary artery calcification.

METHODS: This was a cross sectional study on 60 central-obese non-diabetic men, of an average age of 55.2 years, with evidence of coronary calcification, who came for health check-up and met the inclusion criteria consecutively as defined by waist circumference >90 cm and fasting blood glucose <126 mg/dL. Coronary calcification was defined by coronary artery calcium (CAC) score ≥10 Agatson-unit Dual Source 64 slice CT scan.

RESULTS: There is positive correlation between hypertension and BMP-2 in central-obese non-diabetic men with evidence of coronary artery calcification. BMP-2 plasma concentration was higher in the hypertensive subjects. The correlation was stronger in younger (<55 years old) subjects and subjects with insulin-resitance.

KEYWORDS: hypertension, BMP-2, coronary calcification, central obesity, age, insulin resistance


Full Text:

PDF

References


Schauer IE, Snell-Bergeon JK, Bergman BC, Maahs DM, Kretowski A, Eckel RH, et al. Insulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes: The CACTI study. Diabetes. 2011; 60: 306-14, CrossRef.

Chahwala V, Arora R. Cardiovascular manifestations of insulin resistance. Am J Ther. 2009; 16: e14-28, CrossRef.

Derwall M, Malhotra R, Lai CS, Beppu Y, Aikawa E, Seehra JS, et al. Inhibition of bone morphogenetic protein signaling reduces vascular calcification and atherosclerosis. Arterioscler Thromb Vasc Biol. 2012; 32: 613-22, CrossRef.

Rodrigues TC, Veyna AM, Haarhues MD, Kinney GL, Rewers M, Snell-Bergeon JK. Obesity and coronary artery calcium in diabetes: the coronary artery calcification in type 1 diabetes (CACTI) study. Diabetes Technol Ther. 2011; 13: 991-6, CrossRef.

Jamjoum LS, Bielak LF, Turner ST, Sheedy IP, Boerwinkle E, Raghunathan TE, et al. Relationship of blood pressure measures with coronary artery calcification. Med Sci Monit. 2002; 8: CR775-81, PMID.

Mayer B, Lieb W, Radke PW, Gotz A, Fischer M, Bassler A, et al. Association between arterial pressure and coronary artery calcification. J Hypertens. 2007; 25: 1731-8, CrossRef.

Rodrigues TC, Canani LH, Schvartzman P, Gross JL. Hypertension is the metabolic syndrome component most strongly associated with microvascular complications and coronary artery calcification in Type 1 diabetes. J Endocrinol Invest. 2011; 34: e58-63, CrossRef.

McEniery CM, McDonnell BJ, So A, Aitken S, Bolton CE, Munnery M, et al. Aortic calcification is associated with aortic stiffness and isolated systolic hypertension in healthy individuals. Hypertension. 2009; 53: 524-31, CrossRef.

Jensky NE, Criqui MH, Wright MC, Wassel CL, Brody SA, Allison MA. Blood pressure and vascular calcification. Hypertension. 2010; 55: 990-7, CrossRef.

Csiszar A, Lehoux S, Ungvari Z. Hemodynamic forces, vascular oxidative stress, and regulation of BMP-2/4 expression. Antioxid Redox Signal. 2009; 11: 1683-97, CrossRef.

Zhang M, Zhou SH, Zhao SP, Liu QM, Li XP, Shen XQ. Irbesartan attenuates Ang II-induced BMP-2 expression in human umbilical vein endothelial cells. Vasc Med. 2008; 13: 239-45, CrossRef.

Csiszar A, Smith KE, Koller A, Kaley G, Edwards JG, Ungvari Z. Regulation of bone morphogenetic protein-2 expression in endothelial cells: role of nuclear factor-kappaB activation by tumor necrosis factor-alpha, H2O2, and high intravascular pressure. Circulation. 2005; 111: 2364-72, CrossRef.

Raggi P, Gongora MC, Gopal A, Callister TQ, Budoff M, Shaw LJ. Coronary artery calcium to predict all-cause mortality in elderly men and women. J Am Coll Cardiol. 2008; 52: 17-23, CrossRef.

Shaw LJ, Raggi P, Schisterman E, Berman DS, Callister TQ. Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality. Radiology. 2003; 228: 826-33, CrossRef.

Csiszar A, Ahmad M, Smith KE, Labinskyy N, Gao Q, Kaley G, et al. Bone morphogenetic protein-2 induces proinflammatory endothelial phenotype. Am J Pathol. 2006; 168: 629-38, CrossRef.

Sweatt A, Sane DC, Hutson SM, Wallin R. Matrix Gla protein (MGP) and bone morphogenetic protein-2 in aortic calcified lesions of aging rats. J Thromb Haemost. 2003; 1: 178-85, CrossRef.

Meier U, Gressner AM. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem. 2004; 50: 1511-25, CrossRef.

Zhang H, Schulz TJ, Espinoza DO, Huang TL, Emanuelli B, Kristiansen K, et al. Cross talk between insulin and bone morphogenetic protein signaling systems in brown adipogenesis. Mol Cell Biol. 2010; 30: 4224-33, CrossRef.

Hirose H, Saito I, Kawabe H, Saruta T. Insulin resistance and hypertension: seven-year follow-up study in middle-aged Japanese men (the KEIO study). Hypertens Res. 2003; 26: 795-800, CrossRef.

Anderson EA, Mark AL. The vasodilator action of insulin: Implications for the insulin hypothesis of hypertension. Hypertension. 1993; 21: 136-41, CrossRef.




DOI: https://doi.org/10.18585/inabj.v3i3.149

Indexed by:

                 

                  

               

     

 

The Prodia Education and Research Institute